$3.75
9.65%
Nasdaq, Nov 21, 10:00 pm CET

Maravai LifeSciences Stock price

$3.75
+0.38 11.28% 1M
+1.50 66.67% 6M
-1.70 31.19% YTD
-1.21 24.40% 1Y
-10.40 73.50% 3Y
-25.25 87.07% 5Y
-26.10 87.44% 10Y
-26.10 87.44% 20Y
Nasdaq, Closing price Fri, Nov 21 2025
+0.33 9.65%

Key metrics

Basic
Market capitalization
$958.9m
Enterprise Value
$1.0b
Net debt
$80.6m
Cash
$243.6m
Shares outstanding
255.4m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
5.0 | 4.9
EV/Sales
5.4 | 5.3
EV/FCF
negative
P/B
3.9
Financial Health
Equity Ratio
32.3%
Return on Equity
-44.5%
ROCE
-16.8%
ROIC
-21.9%
Debt/Equity
1.3
Financials (TTM | estimate)
Revenue
$192.3m | $195.8m
EBITDA
$-130.6m | $-31.2m
EBIT
$-132.4m | $-79.3m
Net Income
$-121.2m | $-81.9m
Free Cash Flow
$-66.8m
Growth (TTM | estimate)
Revenue
-30.6% | -24.5%
EBITDA
-1,745.0% | 54.2%
EBIT
-193.3% | -12.2%
Net Income
46.0% | 43.4%
Free Cash Flow
-474.1%
Margin (TTM | estimate)
Gross
20.9%
EBITDA
-67.9% | -15.9%
EBIT
-68.9%
Net
-63.1% | -41.8%
Free Cash Flow
-34.8%
More
EPS
$-0.8
FCF per Share
$-0.3
Short interest
10.6%
Employees
580
Rev per Employee
$450.0k
Show more

Is Maravai LifeSciences a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,052 stocks worldwide.

Maravai LifeSciences Stock Analysis

Unlock Scores for Free

Analyst Opinions

17 Analysts have issued a Maravai LifeSciences forecast:

10x Buy
59%
7x Hold
41%

Analyst Opinions

17 Analysts have issued a Maravai LifeSciences forecast:

Buy
59%
Hold
41%

Financial data from Maravai LifeSciences

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
192 192
31% 31%
100%
- Direct Costs 152 152
2% 2%
79%
40 40
69% 69%
21%
- Selling and Administrative Expenses 153 153
4% 4%
80%
- Research and Development Expense 18 18
3% 3%
9%
-131 -131
1,745% 1,745%
-68%
- Depreciation and Amortization 1.80 1.80
97% 97%
1%
EBIT (Operating Income) EBIT -132 -132
193% 193%
-69%
Net Profit -121 -121
46% 46%
-63%

In millions USD.

Don't miss a Thing! We will send you all news about Maravai LifeSciences directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Maravai LifeSciences Stock News

Neutral
Business Wire
14 days ago
SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conference during the month of November. On November 12, 2025, at 10:00 a.m. EST, Raj Asarpota, Chief Financial Officer, will participate in a fireside chat at the Stifel Health...
Neutral
Seeking Alpha
17 days ago
Maravai LifeSciences Holdings, Inc. ( MRVI ) Q3 2025 Earnings Call November 6, 2025 5:00 PM EST Company Participants Debra Hart - Senior Director of Investor Relations Bernd Brust - CEO & Director Rajesh Asarpota - EVP & Chief Financial Officer Chanfeng Zhao - Senior VP & Chief Scientific Officer Conference Call Participants Justin Bowers - Deutsche Bank AG, Research Division Madeline Mollman -...
Neutral
Business Wire
18 days ago
SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the third quarter ended September 30, 2025, together with other business updates. Quarterly Results: Revenue of $41.6 million, Net loss of $(45.1) million, and Adjusted EBITDA...
More Maravai LifeSciences News

Company Profile

Maravai Lifesciences Holdings, Inc. operates as an investment holding company. It develops biopharmaceuticals. The company is headquartered in San Diego, CA.

Head office United States
CEO William Martin
Employees 580
Founded 2014
Website www.maravai.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today